Log In
BCIQ
Print this Print this
 

BBI-3000 oral

  Manage Alerts
Collapse Summary General Information
Company Brickell Biotech Inc.
DescriptionOral retinoid acting as a highly selective RXR agonist
Molecular Target Retinoid X receptor (RXR)
Mechanism of ActionRetinoid X receptor (RXR) agonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today